REFERENCES
- Boudreau, E. F., Webster, H. K., Pavanond, K. & Thosingha, L. (1982). Type II mefloquine resistance in Thailand. Lancet, ii, 1335.
- Bruce-Chwatt, L. J. (1981) (Ed.). Chemotherapy of Malaria, 2nd Edn. Geneva: WHO.
- Bunnag, D., Santharasamai, P., Migasena, S., Charoenlarp, P., Harinasuta, T., Maliku, S. & Pinichpongse, S. (1983). Chemotherapy of Chloroquine Resistant Malaria: Yearly Monitoring, p. 93, ISBN 974-7980-39. Malaria Research, Thailand. Malaria Division, Government of Thailand.
- Chongsuphajaisiddhi, T., Sabcharoen, A. & Phanorsri, A. (1981). In vivo and in vitro sensitivity of falciparum malaria to quinine in Thai children. Annals of Tropical Paediatrics, 1, 21–26.
- Duriyananda, D. & Noeypatimanond, S. (1981). Quinine-resistant falciparum malaria: case report. Journal of the Medical Association of Thailand, 65, 395–397.
- Ellerbrook, L. D., Lippincott, S. W., Caterro, C. F., Gordon, H. H. & Marble, A. (1945). Plasma quinacrine concentration in treatment of Plasmodium vivax malaria acquired in the South Pacific. Archives of Internal Medicine, 76, 352–357.
- Harinasuta, T., Suntharasamai, P. & Viravan, C. (1965). Chloroquine-resistant malaria in Thailand. Lancet, ii, 657–660.
- Markell, E. K. & Voge, M. (1981). Medical Parasitology, 5th Edn. Philadelphia: W. B. Saunders.
- Phillips, R. E., Looareesuwan, S., Karbwang, J., Warrell, D. A., White, N. J., Kasemsarn, P. & Warhurst, D. C. (1984). Failure of chloroquine—erythromycin and chloroquine—tetracycline combinations in the treatment of chloroquine-resistant falciparum malaria. Lancet, ii, 300–302.
- Pinswadi, K. & Charoenkwan, P. (1965). Sluggish response of a case of falciparum malaria to intensive quinine therapy. Journal of the Medical Association of Thailand, 48, 386–389.
- Reacher, M., Campbell, C. C., Freeman, J., Doberstyn, E. B. & Brandling-Bennett, A. D. (1981). Drug therapy for Plasmodium falciparum malaria resistant to pyrimethamine sulfaxodine (Fansidar). Lancet, ii, 1066–1068.
- Rollo, I. M. (1975). Drugs used in the chemotherapy of malaria. In The Pharmacological Basis of Therapeutics, eds. Goodman, L. S. & Gilman, A., 5th Edn, p. 1049. New York: Macmillan.
- Rowland, M. & Tozer, T. L. (1980). Clinical Pharmacokinetics, Concepts and Applications. Philadelphia: Lea & Febinger.
- Sabchareon, A., Chongsuphajaisiddhi, T. & Attanath, P. (1980). Treatment of giardiasis in children with quinacrine, metronidazole, tinidazole, and ernidazole. South East Asian Journal of Tropical Medicine and Public Health, ii, 280–284.
- Shannon, J. A., Earle, D. P., Brodie, B. B., Taggart, J. V. & Berliner, R. W. (1944). The pharmacological basis for the rational use of atabrine in the treatment of malaria. Journal of Pharmacology, 81, 307–330.
- Taggart, J. V., Earle, D. P., Berliner, R. W., Welch, W. J., Zubrod, C. G., Vailer, J. W., Kuhn, B. H., Norwood, J. & Shannon, J. A. (1948). Studies on the chemotherapy of the human malarias. V. The antimalarial activity of quinacrine. Journal of Clinical Investigation, 27, 93–97.
- Webster, H. K., Thaitthong, S., Pavanond, K., Yongvanitchit, K., Pinswadi, C. & Boudreau, E. F. (1985). Cloning and characterization of mefloquine-resistant plasmodium falciparum from Thailand. American Journal of Tropical Medicine, 34, 1022–1027.
- Wolfe, M. S. (1978). Giardiasis. New England Journal of Medicine, 298, 319–321.
- Young, M. D. & Eyles, D. E. (1948). The efficacy of chloroquine, quinacrine, quinine and totaquine in the treatment of plasmodium malariae infections (Quartan malaria). American Journal of Tropical Medicine, 28, 23–28.